A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension Intervention:   Combination Product: Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI) Sponsor:   Respira Therapeutics, Inc. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials